However, routine thyroid ultrasound monitoring is not recommended solely due to GLP-1 treatment
Common Side Effects of Mounjaro Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist administered via weekly subcutaneous injection
Weight loss averaged 17.5% in just 24 weeks, and with longer use at the highest dose, it reached almost 29%
It depends on your health history, current medications, and cardiovascular picture, and it is reviewed by our nurse practitioner team alongside your lab work
Retatrutide dosage protocols from clinical research Understanding the dosage protocols used in published clinical trials provides essential context for researchers designing their own protocols
While not everyone will experience constipation, those who do may face an increased risk of hemorrhoids due to straining and prolonged sitting during bowel movements